Status:
UNKNOWN
A Diagnostic Accuracy Study Testing Fecal Biomarkers In Comparison To Endoscopic Examination
Lead Sponsor:
Universität Duisburg-Essen
Collaborating Sponsors:
Sozialstiftung Bamberg
Enterosan Labor LS SE & Co.KG
Conditions:
Inflammatory Bowel Diseases
Eligibility:
All Genders
18+ years
Brief Summary
In this study it will be explored whether the levels of fecal biomarkers are associated with histologic inflammation of the intestinal mucosa and concomitant alteration of the mucosal permeability. Th...
Detailed Description
For this study inpatients and outpatients of the clinic for integrative medicine and naturopathy Bamberg, Germany, who had a routine gastroscopy and/or coloscopy with tissue biopsy or an endoscopy wit...
Eligibility Criteria
Inclusion
- Adults
- Signed declaration of consent
- Presence of a confirmed diagnosis of
- Inflammatory bowel diseases
- Irritable bowel syndrome
- Gastrointestinal diseases, except participants with diagnosis of group 1 or 2 (e.g. celiac disease, food allergies, microscopic colitis, diverticulosis, diverticulitis)
- Healthy controls as part of a preventive medical check-up
Exclusion
- No indication for endoscopic examination as part of routine care
- Age under 18 years
Key Trial Info
Start Date :
July 13 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2023
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04849936
Start Date
July 13 2020
End Date
August 1 2023
Last Update
May 18 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sozialstiftung Bamberg, Klinik für Intergrative Medizin
Bamberg, Bavaria, Germany, 96049